Tucson, AZ – According to filings with the U.S. Securities and Exchange Commission, Radiance Therapeutics is raising $7,026,235.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Laurence Marsteller played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Radiance Therapeutics

Radiance Therapeutics is developing a next-generation ophthalmic beta therapy applicator.

To learn more about Radiance Therapeutics, visit http://radiancetherapeutics.com/

Contact:
Laurence Marsteller, Chief Executive Officer
520-582-0960
https://www.linkedin.com/in/laurencemarstellermd/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved